找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: TRAIL, Fas Ligand, TNF and TLR3 in Cancer; Olivier Micheau Book 2017 Springer International Publishing AG 2017 TRAIL.Fas Ligand.TRAIL-R1.T

[复制链接]
查看: 25358|回复: 50
发表于 2025-3-21 19:59:17 | 显示全部楼层 |阅读模式
书目名称TRAIL, Fas Ligand, TNF and TLR3 in Cancer
编辑Olivier Micheau
视频video
概述Provides an up-to-date overview of TNF family signal transduction with a special emphasis on TRAIL and Fas L.Deals with cell biology, immunology and oncology and in particular drug-resistance mechanis
丛书名称Resistance to Targeted Anti-Cancer Therapeutics
图书封面Titlebook: TRAIL, Fas Ligand, TNF and TLR3 in Cancer;  Olivier Micheau Book 2017 Springer International Publishing AG 2017 TRAIL.Fas Ligand.TRAIL-R1.T
描述.This volume provides the current understanding of death receptor‘s/TLR3 signaling regulation in cancer. Death receptors, including TRAIL-R1, TRAIL-R2, Fas and TNF-RI, owing to their ability to trigger apoptosis and to contribute to the elimination of cancer cells by the immune system have been considered, to variable extent, as important therapeutic targets for cancer therapy. But an increasing body of evidence suggests that some of these receptors may also contribute to tumorigenesis, or that new players such as TLR3 may be targeted for cancer therapy due to their ability to behave like death receptors..
出版日期Book 2017
关键词TRAIL; Fas Ligand; TRAIL-R1; TRAIL-R2; TNF-RI
版次1
doihttps://doi.org/10.1007/978-3-319-56805-8
isbn_softcover978-3-319-86006-0
isbn_ebook978-3-319-56805-8Series ISSN 2196-5501 Series E-ISSN 2196-551X
issn_series 2196-5501
copyrightSpringer International Publishing AG 2017
The information of publication is updating

书目名称TRAIL, Fas Ligand, TNF and TLR3 in Cancer影响因子(影响力)




书目名称TRAIL, Fas Ligand, TNF and TLR3 in Cancer影响因子(影响力)学科排名




书目名称TRAIL, Fas Ligand, TNF and TLR3 in Cancer网络公开度




书目名称TRAIL, Fas Ligand, TNF and TLR3 in Cancer网络公开度学科排名




书目名称TRAIL, Fas Ligand, TNF and TLR3 in Cancer被引频次




书目名称TRAIL, Fas Ligand, TNF and TLR3 in Cancer被引频次学科排名




书目名称TRAIL, Fas Ligand, TNF and TLR3 in Cancer年度引用




书目名称TRAIL, Fas Ligand, TNF and TLR3 in Cancer年度引用学科排名




书目名称TRAIL, Fas Ligand, TNF and TLR3 in Cancer读者反馈




书目名称TRAIL, Fas Ligand, TNF and TLR3 in Cancer读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:48:05 | 显示全部楼层
第100159主题贴--第2楼 (沙发)
发表于 2025-3-22 04:24:18 | 显示全部楼层
板凳
发表于 2025-3-22 06:22:47 | 显示全部楼层
第4楼
发表于 2025-3-22 11:22:24 | 显示全部楼层
5楼
发表于 2025-3-22 14:40:59 | 显示全部楼层
6楼
发表于 2025-3-22 18:22:19 | 显示全部楼层
7楼
发表于 2025-3-23 00:29:03 | 显示全部楼层
8楼
发表于 2025-3-23 05:07:39 | 显示全部楼层
9楼
发表于 2025-3-23 06:57:31 | 显示全部楼层
10楼
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-22 05:06
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表